BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Dear Doctor Letter (Rote-Hand-Brief) on systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection

2018.10.26

Active substance: fluoroquinolones

The marketing authorisation holders of fluoroquinolone-containing medicinal products would like to inform about a new warning regarding the risk of aortic aneurysm and dissection associated with the use of systemic or inhaled fluoroquinolones.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 2MB, File is accessible